Cargando…
Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index
Purpose: Biopharmaceutics classification system (BCS) class IV compounds, exhibits least oral bioavailability, low solubility and intestinal permeability among all pharmaceutical classes of drugs. Thus, these drugs need more compatible and efficient delivery system. Since, their solubility in variou...
Autores principales: | Kumar, Sachin, Kaur, Ramneek, Rajput, Rashi, Singh, Manisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311639/ https://www.ncbi.nlm.nih.gov/pubmed/30607334 http://dx.doi.org/10.15171/apb.2018.070 |
Ejemplares similares
-
Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?
por: Kaneko, Kenichi, et al.
Publicado: (2022) -
Quantum leaps
por: Bernstein, Jeremy
Publicado: (2009) -
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
por: Markovic, Milica, et al.
Publicado: (2020) -
Study of the effect of active pharmaceutical ingredients of various classes of BCS on the parameters of thermosensitive systems based on poloxamers
por: Bakhrushina, E.O., et al.
Publicado: (2023) -
A quantum engine in the BEC–BCS crossover
por: Koch, Jennifer, et al.
Publicado: (2023)